Krilogy Financial LLC Makes New $7.81 Million Investment in SPDR S&P Biotech ETF $XBI

Krilogy Financial LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 61,107 shares of the exchange traded fund’s stock, valued at approximately $7,813,000.

A number of other institutional investors have also recently modified their holdings of the business. Compass Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter worth about $1,167,000. China Universal Asset Management Co. Ltd. grew its holdings in SPDR S&P Biotech ETF by 868.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after purchasing an additional 4,411 shares during the period. Ashton Thomas Private Wealth LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $417,000. Altfest L J & Co. Inc. increased its position in shares of SPDR S&P Biotech ETF by 63.1% in the third quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock valued at $12,517,000 after buying an additional 48,326 shares in the last quarter. Finally, Brian Low Financial Group LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $668,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $138.67 on Monday. SPDR S&P Biotech ETF has a 1-year low of $74.67 and a 1-year high of $139.19. The company has a market cap of $9.15 billion, a price-to-earnings ratio of 11.47 and a beta of 0.88. The stock has a 50 day simple moving average of $126.35 and a 200-day simple moving average of $121.02.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.